United Therapeutics (UTHR) is up 34.6%, or $105.59 to $410.35.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UTHR:
- United Therapeutics price target raised to $463 from $314 at BofA
- Promising Developments in United Therapeutics’ Tyvaso Drive Buy Rating Amidst IPF Treatment Advancements
- United Therapeutics price target raised to $564 from $432 at Jefferies
- United Therapeutics rises 42.1%
- United Therapeutics Stock (UTHR) Rockets 40% on Clinical Trial Results